<- Go Home
DiaSorin S.p.A.
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic LIAISON chemiluminescence analyzers under LIAISON XL and LIAISON XS name; and Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Market Cap
EUR 5.0B
Volume
137.2K
Cash and Equivalents
EUR 344.0M
EBITDA
EUR 367.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 781.0M
Profit Margin
65.91%
52 Week High
EUR 112.35
52 Week Low
EUR 82.72
Dividend
1.29%
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
EUR 5.6B
Enterprise Value / EBITDA
15.20
Operating Income
EUR 264.0M
Return on Equity
11.21%
Return on Assets
5.29
Cash and Short Term Investments
EUR 344.0M
Debt
EUR 962.0M
Equity
EUR 1.8B
Revenue
EUR 1.2B
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium